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Abstract
Background: The c-fos proto-oncogene is an archetype for rapid and integrative transcriptional activation. Innumerable
studies have focused on the canonical promoter, located upstream from the transcriptional start site. However, several
regulatory sequences have been found in the first intron.
Methodology/Principal Findings: Here we describe an extremely conserved region in c-fos first intron that contains a
putative TATA box, and functional TRE and CRE sites. This fragment drives reporter gene activation in fibroblasts, which is
enhanced by increasing intracellular calcium and cAMP and by cotransfection of CREB or c-Fos/c-Jun expression vectors. We
produced transgenic mice expressing a lacZ reporter controlled by the intronic promoter. Lac Z expression of this promoter
is restricted to the developing central nervous system (CNS) and the mesenchyme of developing mammary buds in
embryos 12.5 days post-conception, and to brain tissue in adults. RT-QPCR analysis of tissue mRNA, including the anlage of
the mammary gland and the CNS, confirms the existence of a novel, nested mRNA initiated in the first intron.
Conclusions/Significance: Our results provide evidence for a novel, developmentally regulated promoter in the first intron
of the c-fos gene.
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Introduction
The c-fos proto-oncogene product, c-Fos, dimerizes with
members of the Jun family to form the transcription factor AP-
1, which regulates a wide array of genes in response to many
stimuli [1]. c-fos gene activation has been extensively studied
because it exemplifies the rapid, transient response to extracel-
lular stimuli. c-fos is kept silent in most cell types but is robustly
induced by a wide range of agents [2] including: mitogens [3],
cellular stresses such as UV irradiation [4] and mechanical
stretch [5], synaptic stimulation [6], and lymphocyte activation
[7]. Induction is usually transient: c-fos mRNA accumulation
peaks 15–30 min post-induction and disappears after 1 h,
reflecting both transcriptional shut-off and mRNA destabilization
[8,9].
These features make c-fos an exquisite model for studies on
transcriptional control, and the regulatorysequences in its promoter
have been extensively studied. These include sites required for the
response to cytokines (SIE, [10]), serum growth factors (SRE,
[8,11,12]), calcium and cAMP (CRE, [13,14]). Transcription
factors that bind these elements have been identified: STAT1 and
3 (SIE) [15], SRF and TCF (SRE) [16,17], and members of the
CREB/ATF family (CRE, reviewed in [18]).
However, c-fos expression in vivo cannot be explained by a one
signal/one transcription factor/one promoter element reductionism.
Indeed, Robertson and coworkers showed in transgenic mice that c-
fos regulation could only be faithfully mimicked by a reporter
controlled by the whole gene sequence [19]. Moreover, using
mutants of the SIE, SRE, FAP and CRE sequences, they showed
that inactivation of any of these sites led to a dramatic loss of basal
and induced activity [19]. These data are consistent with results of
Herrera and coworkers, showing that a nucleosome settles in the
middle of the promoter and persists throughout the gene activation
cycle [20]. Taken together, this suggests that higher order complexes
involving specific transcription activators, coactivators and the so-
called « basal » transcriptional apparatus integrate diverse signals to
elaborate a controlled response.
Moreover, studies from our laboratory and others identified
intragenic transcription control regions. First, the 59 part of the
first intron contains sequences required for a transcription
elongation block that occurs 385 bp downstream the start site in
vitro [21] and in cells [22]. This blockade is relieved by calcium
signalling [23–25] through a novel pathway [22], and contributes
to rapid activation in this context. Second, a Fos Intragenic
Regulatory Element (FIRE) was identified [26] that appears to be
independent of the elongation block [21,22].
In addition, DNase I-hypersensitive sites in the c-fos gene map to
the SRE and the transcription start site (TSS), and to two
intragenic positions, at +200 and +700 relative to the TSS [27],
that presumably correspond to regulatory sites. The +200 region
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to the conserved region described in this work.
c-fos expression has been followed during mouse development
using in situ hybridization on frozen embryo sections. c-fos mRNA
was first detected in developing bone and cartilage in E17–E18
embryos [28]. Accordingly, c-fos gene knockout mice exhibit a
severe bone development defect, osteopetrosis [29,30], due to a
defect in osteoclast differentiation [31]. The lack of more
widespread phenotypes in c-fos null mice indicates that, in spite
of its apparently ubiquitous role in proliferation and differentiation
of cultured cells, c-Fos functions can largely be compensated by
other Fos family members.
Here we show that c-fos first intron contains a region that is
highly conserved from Xenopus to man, and contains binding sites
for TBP (TATA box), along with the AP-1 and CREB families of
transcription factors. This region promotes luciferase reporter
gene expression in fibroblasts. Moreover, this promoter activity is
enhanced by activating cAMP and Ca
2+ signaling pathways, as
well as by ectopic expression of CREB, c-Fos and c-Jun. To test its
activity in vivo, we produced transgenic mice carrying a construct
in which the intronic sequence controls expression of LacZ.
Transgenic embryos show LacZ expression in various areas of the
CNS throughout development, and in the developing mammary
gland at days 12.5 to 13.5 p.c. We confirmed by RT-QPCR that
this novel promoter activity actually produces a messenger RNA in
vivo. Our results suggest that previous data on c-fos regulation
should be re-evaluated in light of the existence of this new
promoter.
Results
Sequences within the 39 part of c-fos first intron have
been conserved through evolution.
We compared c-fos mouse genomic sequences with those from
Homo sapiens, Sus scrofa, Gallus gallus, Xenopus laevis [32], Fugu rubripes
and Danio rerio (see Methods section for accession numbers), using
the VISTA genome server. We noticed an extremely conserved
region in intron 1, even more conserved than c-fos exons (fig. 1A).
A nucleotide alignment of the 39 part of this c-fos intron 1 shows
that between nucleotides +619 to +849 relative to the murine TSS,
43% nucleotides are strictly identical in five species (fig. 1B). Such
a degree of conservation suggests high selective pressure. In
addition, this intron spans ca. 400 bp in the c-fos ortholog from
Fugu rubripes, an organism which has a very compact genome with
rare introns. Strikingly, the sequences from Fugu rubripes and Mus
musculus are 50% identical (when aligning nucleotides +692 to
+792 relative to the mouse gene, not shown). Taken together,
these observations suggest that this part of the c-fos gene has an
important regulatory function. In addition, three ESTs
(AU079352, AU080182 and BY729407) from mouse adult brain
and embryo spinal cord map in this intronic region (fig. 1A),
suggesting that it contains an alternative promoter with a
preference for neural tissue.
Strikingly, this region harbors DNA sequences that resemble
consensus binding sequences for AP-1 (TRE) and CREB (CRE)
families of bZIP transcription factors, immediately upstream of a
putative TATA box (fig. 1B, in blue). These sites show strong
conservation from Xenopus to man and were detected at high
stringency by the Alibaba program (see Methods section) that
predicts transcription factor binding sites.
Consistent with this region being a putative promoter, sequence
conservation is high upstream of the TATA box, and drops
sharply just after it. In the Neural Network Promoter Prediction
program (see Methods section), the region encompassing these
conserved sites obtained a score of 0.92, where the score for the
canonical promoter, defined as nucleotides 2360 to +1, was 1.0.
These observations strongly suggest that this intronic region could
be a functional promoter.
Intronic CRE and TRE sites bind transcription factors of
the CREB and AP-1 families in vitro.
Given its high degree of conservation and similarity to TRE and
CRE sites, we first tested its ability to recruit transcription factors
in vitro. Multiple complexes were observed in an Electrophoretic
Mobility Shift Assay using Hela cell nuclear extracts and a
radioactive probe containing both putative sites (fig. 2A, lane 2).
Competition experiments using an excess of unlabeled wt probe
blocked complex formation (lanes 3, 4). Similarly, competing DNA
mutated in a single site (lanes 5, 6, 7, 8) showed that band b
corresponds to complexes on the TRE, while band a represents
binding to the CRE. The bands c and d are not fully competed
and may reflect binding activities capable of recognizing either
site. Competition with an excess of the double mutant probe (lanes
9 and 10) had no effect, showing that they are specific for the TRE
and CRE.
We then used antibodies specific for the AP-1 and CREB
families of transcription factors to confirm that the complexes
obtained in fig. 2A contained these factors. Antibodies to ATFa
(fig. 2B, lane 5) and CREM (lane 9) had no detectable effect on the
complexes. Antibodies to c-Fos (lane 3) and c-Jun (lane 4)
disrupted the b, and a plus b complexes, respectively. Anti-JunB
(lane 7) also reduced complex a. Antibodies to ATF-1 (lane 6) led
to multiple supershifted complexes and the loss of complexes c and
d. Anti-CREB-1 (lane 8) led to a weak supershift of complex a.N o
effect was seen in the absence of nuclear extract (not shown).
Hence, consistent with the competition data, band b is likely to be
AP-1 (c-Jun/c-Fos dimers) on the TRE site, while band a
corresponds to CREB and c-Jun-containing complexes on the
CRE site. Bands c and d seem to represent binding by ATF-1-
containing complexes.
Thus the TRE and CRE sites are genuine in vitro binding sites
for the AP-1 and CREB families of transcription factors.
Figure 1. An extremely conserved region in c-fos first intron: evidence for a nested promoter. A. c-fos gene conservation profile between
the mouse gene and 6 other indicated species (VISTA genome server). The baseline corresponds to 50% identity for human, pig and chicken
genomes, and to 0% identity for xenopus, fugu, and zebrafish genomes in 100 bp windows. Peaks culminating at more than 70% identity (in 100 bp
windows) are painted in pink by the software. Note that the 39 half of first intron is more conserved than surrounding exons in the four top species.
Confirmed start site for canonical mRNA and putative intronic mRNA appear respectively as blue and black broken arrows. A CpG island (green box)
extends from the canonical promoter to the putative intronic promoter. Blue boxes represent exons, black mRNAs correspond to the putative mRNA
starting in the conserved region and three ESTs previously sequenced and mapping to the same region (UCSC genome server). DNase I
hypersensitive sites from Renz et al. are shown as black downward arrows. B. Nucleotide alignment of the most conserved part of c-fos first intron
(from +619 to +849 relative to mouse canonical TSS) from 5 species (pig, human, mouse, chicken, xenopus). Asterisks depict nucleotides identical in
all 5 species. Conservation culminates in motifs resembling a TRE, a CRE, and a TATA box (shown in blue). Red and green sequences respectively
correspond to primers 1 and 2 used in figure 6.
doi:10.1371/journal.pone.0011235.g001
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luciferase expression in transfected cells.
We designed the fiL reporter construct (fos intron Luciferase,
fig. 3A, see methods) to check for intronic promoter activity in
transient transfection assays. Interestingly, this construct gives
significantly higher basal luciferase activity than the promoterless
vector (pGL2-basic) in NIH 3T3 cells (fig. 3B), along with MEFs
and CCL39 cells (Mouse Embryo Fibroblasts, Chinese Hamster
Lung Fibroblasts; not shown). Furthermore, this activity is
stimulated by agonists that elevate intracellular calcium and
cAMP levels, the calcium ionophore A23187 and forskolin: they
both lead to a 3-fold increase in promoter activity (fig. 3C) that was
not observed with the promoter-less vector (pGL2-basic, not
shown). The phorbol ester PMA did not enhance the intronic
promoter activity, alone or together with A23187 and forskolin.
Similarly, the combination of A23187 and forskolin did not
increase intron promoter activity much over that seen with
forskolin alone.
Since the region of interest contains CRE and TRE sites and
responds to calcium and cAMP, we checked whether its activity
was stimulated by expression vectors for AP-1 or CREB, which
mediate responses to activation of calcium and cAMP pathways.
While transfection of FosB, Fra-1, Fra-2, JunB or JunD did not
stimulate the fiL reporter gene (not shown), the CREB expression
vector stimulated fIL activity 6-fold (fig. 3D). Similarly, cotransfec-
tion of c-Fos and c-Jun expression vectors led to a 7-fold
stimulation, not seen with either vector alone (fig. 3D).
Considering the in vitro effect of CREB and AP-1 factors on
intron 1-driven transcription, we felt compelled to test the activity
of the intronic promoter in vivo using transgenic mice.
The c-fos intronic promoter directs b-galactosidase
expression in specific stages and tissues of mice
development.
In order to identify when and where the c-fos intronic promoter
is active in mouse embryos, we constructed the fiZ transgene (fos
intron LacZ, fig. 4A, see methods). As in the case of the fiL construct
described before, this transgene contains no previously described
promoter sequence. Fusing b-galactosidase to a nuclear localiza-
tion signal (NLS) allows us to discriminate between it and the
endogenous, cytoplasmic b-galactosidase activity [33].
The transgenesis procedure yielded 7 founders, 5 of which
expressed LacZ activity during embryonic development. The
expression territories were remarkably restricted. In addition to
some ectopic expression due to random transgene insertion sites
(Table 1), the fiZ embryos showed expression in the mesenchymal
part of the mammary gland anlage from E12.5 to E13.5 (4/5
mouse lines, see fig. 4D, F, G–J). Another preferential site of
expression was the developing CNS: 3/5 mouse lines showed
transient fiZ expression in the spinal cord and hindbrain at E11.5
to E12.5 (fig. 4C–D). Embryonic sections revealed that b-
galactosidase activity was nuclear (fig.4H–K), and thus resulting
from expression of the fiZ transgene, not endogenous b-
galactosidase. In addition, transverse sections showed that, in the
spinal cord, only a few cells per section expressed the transgene
(fig. 4K). These cells are located in the ventral part of the mantle
Figure 2. The intronic TRE and CRE sites bind members of the
CREB and AP-1 families of transcription factors. EMSA using HeLa
nuclear extractsand probes corresponding to the TRE and CRE sites of c-fos
firstintron. A. Competitionanalysiswithnon-radioactive probeswt (lanes 3,
4) or mutated on the TRE (lanes 5, 6), the CRE (lanes 7, 8), or both (lanes 9,
10). Lane 1 shows the probe without extract, lane 2 with extract but
without competing cold probe. B. Disruption or supershift of the protein/
DNA complexes. The probe (lane 1) was incubated with HeLa nuclear
extract (lanes 2 to 9) and antibodies to c-Fos (lane 3), c-Jun (lane 4), ATF-a
(lane 5), ATF-1 (lane 6), JunB (lane 7), CREB-1 (lane 8), and CREM (lane 9).
doi:10.1371/journal.pone.0011235.g002
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neurons. The linear aspect of the staining along the rostrocaudal
axis of embryos also suggests that it represents a functional
population of neurons from the same motor column.
To further characterize the intronic promoter, we tested fiZ
expression in newborn and adult mouse tissues (fig.5, table 1). Most
tissues tested, including spinal cord, skeletal muscle, spleen, thymus,
heart, lungs, liver, and oesophagus, were negative for LacZ
expression. Staining, when observed,corresponded to tissues known
to express high endogenous b-galactosidase activity, namely
stomach, salivary glands, kidneys, and bones. Interestingly, 3/5
mouse lines showed expression in the newborn (fig. 5A, D, G) and
adult brain (fig. 5B, C, E, F, H, I). Although they were not observed
in non-transgenic animals fig. 5J, K), the structures stained were
overlapping but different in each mouse line, suggesting that the
intronic promoter is likely to contain some brain-specific regulatory
elements that are insufficient to confer full specificity.
Mapping of endogenous mRNA confirms that the
intronic promoter is functional in vivo.
To confirm that LacZ expression in fiZ transgenic embryos
really reflects an endogenous promoter activity, we performed
RT-PCR on total RNA from developing mammary gland tissue
dissected from wild-type E12,5 embryos (fig. 6B). We amplified
fragments of the expected sizes (257 and 213 bp, respectively)
with primers 2 and 3 (lanes d and e), located dowstream the
putative start site. These fragments actually correspond to an
endogenous RNA, since they were not obtained without reverse
transcription (lanes a and b). To rule out any amplification of
residual pre-mRNA from the canonical promoter, we used
primer 1 (shown in red in fig. 1B), located upstream of the
putative intronic start site. This primer yielded a very weak band
(lane f), while it efficiently amplified genomic DNA (lane i). These
data indicate that in the developing mammary bud, there is an
endogenous mRNA that starts in c-fos first intron between
positions +740 and +819 relative to the canonical start site. To
confirm the result with primer 1, we used two additional primers
(primers 0.8 and 0.9) located 126 and 30 bp upstream,
respectively (fig. 6A). Using RT-qPCR on adult mouse cortex
RNA, normalized by the relative efficiencies of the different
primers on a cloned c-fos gene, primers 0.8, 0.9 and 1 similarly
gave very weak signals, i.e. amplified a very low abundance
species (fig. 6C). This confirms that they are targeting c-fos
pre-mRNA rather than the intronic mRNA. The latter was
Figure 3. The c-fos conserved intronic region drives luciferase expression and responds to the CREB and AP-1 pathways. A. 59 part of
mouse c-fos gene (up) and ourreporter construct(bottom), fiL (fos intron Luciferase). B. The fos intronic region suffices todrive Luciferase activityin NIH3T3
cells in transient transfection. The promoterless pGL2 basic vector background activity is shown as a control. Error bars represent standard deviation, n=7.
C. The fIL construct responds to the calcium and cAMP pathways, but not to PMA. NIH3T3 transfected with fiL were treated with the indicated drugs. Error
barscorrespondto standarddeviation,n=6.D.Co-transfectionwithCREBorAP-1expressionvectorsstimulates fILpromoteractivity.Error barscorrespond
to standard deviation, n=5. Statistical analysis of variance (ANOVA) was performed (*: p,0.05; **: p,0.01 relative to control).
doi:10.1371/journal.pone.0011235.g003
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TSS between positions +740 and +819 relative to the canonic
TSS.
To further analyze tissue-specific expression of the endogenous
c-fos intronic RNA, we performed RT-QPCR on RNA extracted
from various adult mouse tissues (fig.6D). Consistent with the
transgenics data, expression was high in the adult cortex and low
in the spinal chord. The adult mammary gland and cerebellum
express low levels, while skin seemed to express intermediate
levels. These data confirm the existence of a transcript starting in
c-fos first intron in vivo, in tissues consistent with the transgenic
analysis.
Figure 4. Transgenic analysis of the putative promoter shows expression restricted to the spinal cord and mammary bud of mouse
embryos. A. 59 part of mouse c-fos gene (up) and our NLS-containing, betagalactosidase reporter construct (bottom), fiZ (fos intron lacZ). 7
Transgenic mouse lines were created with fiZ and transgenic embryos were stained for betagalactosidase activity. Here are shown transgenic
embryos from mouse line #60 at day 10.5 (B), 11.5 (C, K), 12.5 (D, G, H), and 13.5 (F, I, J). B, C, D, F: whole-mount embryos showing the spinal cord
staining starting day 11.5 p. c. and the mammary gland anlage staining starting 12.5 p. c. G. Close-up view of the developing mammary buds showing
the stained ring corresponding to mesenchymal cells. H, I, J: sagittal frozen sections showing the nuclear staining in the mesenchymal part of the
mammary bud, but not in the central, epithelial part. K. Transverse frozen section on a 11.5 d. p. c. embryo showing the extremely restricted, ventral
spinal cord staining. E: wild-type, e13.5 embryo as a control. Scale bars: 1 mm (B, C, D, E, F, G) then 150 mm (H, I, J, K).
doi:10.1371/journal.pone.0011235.g004
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In this work, we describe a region of c-fos first intron that has
been conserved throughout vertebrate evolution. This region
contains TRE and CRE sites that are functional in vitro.I n
transiently transfected fibroblasts, it drives luciferase expression in
the absence of any other promoter, which qualifies it as a genuine
promoter. Importantly, this novel promoter is also active in
transgenic developing embryos and adult brain, and has a very
restricted expression pattern: only the mesenchymal part of the
developing mammary bud and some CNS structures express the
fiZ transgene. Finally, we confirm that an endogenous transcript
resulting from intronic promoter activity exists in embryonic and
adult tissues and starts in the intronic, conserved region.
Strikingly, c-fos first intron was previously pinpointed as one of
the few untranslated regions that were highly conserved through
evolution (our unpublished observation and ACUTS database: see
[34]). While at that time the reason for its conservation was
unclear, we now propose that it is because it performs a novel,
tissue-specific promoter function for the gene.
One report seems to rule out the contribution of intragenic
sequences in calcium- and growth factor-induced c-fos transcrip-
tion [35]. Since the latter study was based on transiently
transfected constructs, these discrepancies could be due either to
the different cell types used or to a requirement for chromatin
structure that is not reproduced on extra-chromosomal templates.
In contrast, several recent reports suggest that c-fos first intron
improves reporter induction by calcium-mobilizing agents when
appended to the upstream promoter ([36–39] and our unpublished
observations). While this effect does not seem to be related to
elongation control, it has not been established by which
mechanisms this region affects overall trancription. Our results
suggest that the enhancing effect measured may in fact be due to
the sum of both canonical and intronic promoter activities.
The relatively high basal activity of the intronic promoter in
transiently transfected fibroblasts (fig. 3B) contrasts with its highly
restricted pattern in transgenic animals (figs. 4 and 5). This could
indicate either the lack of chromatin environment in transient
transfection, or the lack of some molecular determinants in the fiZ
transgene for full widespread expression. Given the difficulties we
experienced trying to detect the endogenous messenger in most
tissues, we favour the first explanation. However, the temporal
patternofexpression asseenintransgenicmice shouldbeconfirmed
on the endogenous target at different stages of development (not
only in adult cortex and e12.5 mammary glands), since it could be
influenced by sequences near the insertion site.
Interestingly, in whole-mount embryos the continuous line of
stained spinal cord cells extends from the hindbrain to the caudal
region. Only one of the known motor columns has such an extended
repartition, the others being restricted to limited segments along the
rostro-caudal axis [40]. Thus it appears that the fiZ-expressing cells
belong to the medial part of the medial motor column (MMCm),
known to contain motor neurons innervating the axial muscles [41].
This pattern is reminiscent of that observed by Caubet [42], where a
c-fos exon 4 probe, revealed a more widespread expression in spinal
cord and brain of E14 embryos than we found. This discrepancy
might be due to the fact that he was detecting expression of both
promoters, and/or that our construct lacks sequences important for
whole CNS expression. Consistent with the latter explanation, we
find that the preferential CNS expression showed integration site-
dependent effects. Interestingly, c-fos2/2 mice were shown to have
defects related to the CNS: apoptosis in the retina [43], altered spatial
learning [44], and an impaired long-term response to kindling [45].
While our data add a novel level of complexity to c-fos
transcription regulation, it is somewhat surprising that this feature
was not discovered before. This can be explained both by the
similar size of the predicted intronic mRNA and the canonic c-fos
mRNA, and its low expression level, which forced us to resort to
PCR-based methods for detection.
The predicted reading frame for this mRNA gives a protein
starting at methionine 111 of canonical c-Fos. The first 110
aminoacids of c-Fos contain two Fos activation modules (FAMs),
an inhibitor domain (ID1), and sequences necessary for cell
transformation and negative cross-talk between AP-1 and the
Glucocorticoid Receptors (GR) [46]. However, using antibodies to
the N- and C-terminal regions of c-Fos, we were unable to detect
c-FosDN protein in adult tissue protein extracts. Nevertheless, it
transactivates a 3xTRE-Luciferase reporter to the same extent as
the full-length c-Fos protein (Coulon V. and Blanchard J. M.,
unpublished), suggesting that the functional differences between
both isoforms might be more subtle. For example, the lack of
interaction with a partner such as the GR would allow c-FosDNt o
be insensitive to its negative control. Interestingly, the GR
performs multiple functions in mammary gland development
and cancer, some of them independent of DNA binding [47],
including mammary gland differentiation in lactating female mice
[48]. This alternate isoform of c-Fos would thus be insensitive to
trans-regulation by corticoids. c-FosDN also lacks a domain
required for cell transformation; it could thus perform some of the
functions of canonical c-Fos, such as transactivation, but would be
unable to trigger cell transformation. Altogether, the tissue-specific
expression of the intron-driven RNA and the primary structure of
this novel Fos protein suggest a new function for the c-fos
proto-oncogene.
Materials and Methods
DNA Sequences and Sequence Analysis
Alibaba, NNPP, BLAST and Clustal programs were used on
their respective internet sites (http://wwwiti.cs.uni-magdeburg.de/
˜grabe/alibaba2/, http://www.fruitfly.org/seq_tools/promoter.
Table 1. Frequency of occurrence of expression patterns for
the fiZ transgene.
Stage Tissue Frequency
Embryo Eye lens 2/5
Vibrissae placodes 1/5
Forebrain 1/5
Forelimb ectoderm 1/5
Forelimb AER 1/5
Mammary gland mesenchyme 4/5
Spinal cord 3/5
hindbrain 4/5
Newborn and adult Brain (different patterns) 3/5
Spinal cord 0/5
Other tissues 0/5
Expression territories which appear in more than two mouse lines are shown in
boldface, the others being considered as possibly due to the influence of fiZ
transgene insertion site. AER stands for Apical Ectodermal Ridge. Different
expression sites in the newborn/adult brain are scored together as ‘‘brain’’, but
since they were not consistent in different transgenic lines, the precise regions
have not been characterized in detail.
doi:10.1371/journal.pone.0011235.t001
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ac.uk/clustalw/). Sequences accession numbers for c-fos gene: Homo
sapiens (VO1512), Sus scrofa (AJ132510), Mus musculus (V00727),
Xenopus laevis (described in [32]), Gallus gallus (M18043), Danio rerio
(NC_007131), Fugu rubripes (ENSTRUG00000010579).
Reagents
DMEM tissue culture medium, penicillin, streptomycin,
glutamine, and random primers DNA labeling system were
obtained from Life Technologies, Inc. (Cergy Pontoise, France).
Phorbol Myristate Acetate (PMA, used at 0.1 mg/ml), forskolin
(used at 50 mM), A23187 (used at 5 mg/ml), X-Gal, potassium
ferricyanide and ferrocyanide were purchased from Sigma-Aldrich
(St. Quentin Fallavier, France). Radioactive nucleotides were from
Amersham Pharmacia Biotech. All products for non-radioactive in
situ hybridization came from Roche (Meylan, France). Cryosec-
tionning materials were from Electron Microscopy Sciences
(Euromedex, Mundolsheim, France) and CML (Nemours,
France). Dual Luciferase Reporter Assay and Riboprobe system
were purchased from Promega France.
Plasmid Constructs
The fiL (fos intron Luciferase) plasmid was constructed by
amplifying by PCR part of c-fos first intron with oligonucleotides
59-actacgaggcgtcatcctcc-39 and 59-gcaagtggccctagtgtcgc-39, and
cleaving the PCR product with XhoI. The resulting fragment
(+579 to +980 relative to the start site) was cloned in pGL2-basic
vector (Promega). The SV40 promoter in pCH110 (Invitrogen)
was deleted from SphI site to KpnI site, and replaced by a cassette
encoding the SV40 NLS (oligonucleotides 59-cctcgagcccgggaag-
Figure 5. Brain-specific but variegated expression in newborn and adults from three different transgenic mouse lines. Newborn pups
(A, D, G) or adult brains (B, C, E, F, H, I) from mouse transgenic lines 3 (A, B, C), 12 (D, E, F), and 21 (G, H, I) were stained for betagalactosidase activity,
along with wild-type controls (J, K). Newborn pups (A, D, G, H) and adult brains (C, F, I, K) were cut sagitally or transversely, respectively, for X-Gal
penetration and structure identification. Note the different patterns of expression in different mouse lines. Asterisks show a territory of endogenous,
cytoplasmic betagalactosidase expression, the nasal pits, also seen in the wild-type controls (J). Scale bars: 5 mm (A, B, D, E, G, H, J) or 1 mm (C, F, I, K).
doi:10.1371/journal.pone.0011235.g005
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ttcttttttggagccattctagaaagcttccc-gggctcgaggcatg-39). Thisprocedure
yielded the pL-NLSLacZ plasmid. The fiZ plasmid (fos intron lacZ)
wasthe resultof cloning the XhoI-BglII fragment ofc-fos gene (+579
to +1058) in the promoter-less, NLS-containing pLNLSLacZ
vector. Expression vectors for AP-1 and CREB factors (maps
available upon request) were constructed by cloning the respective
cDNAs in the pcDNA3 vector (Invitrogen).
Electro Mobility Shift Assays
EMSA were done according to [49]. Briefly, a Hela cell nuclear
extract prepared as described [50] was incubated with a
radioactive, double-stranded probe containing both the TRE
and CRE sites from c-fos intron 1 (probe TRECRE, oligonucle-
otides: 59-ggcgcctgcgtcagcgcagacgtcaggga-39 and 59-ggtccctgacg-
tctgcgctgacgcaggcg-39) and labelled by klenow enzyme and 32P
dCTP. Mutated oligonucleotide cassettes were used for competi-
tions: mTRECRE (oligonucleotides: 59-ggcgcctaagcttgcgcagacgt-
caggga-39 and 59-ggtccctgacgtctgcgcaagcttaggcg-39), TREmCRE
(oligonucleotides: 59-ggcgcctgcgtcagcgcaggatccaggga-39 and 59-
ggtccctggatcctcgcgtgacgcaggcg-39), mTREmCRE (oligonucleo-
tides: 59-ggcgcctaagcttgcgcaggatccaggga-39 and 59-ggtccctggatcct-
gcgcaagcttaggcg-39).
Anti-ATFa monoclonal antibody (2F10) was described [51].
Antibodies to ATF-1, CREM-1 and to Fos and Jun families were
purchased from Santa Cruz Biotech. Anti-CREB-1 was from New
England Biolabs. Antibodies and non-radioactive competitors
were incubated with the Hela cell extract for 15 min at room
temperature before adding the probes for another 15 min.
Transfection and cell culture
NIH3T3 (ATCC CRL-1658
TM), CCL39 (ATCC CCL-39
TM)
and MEF cells were cultured at 37uC in a 5%CO2 incubator, in
Dulbecco’s modified Eagle’s medium containing 10% fetal calf
serum. MEFs were prepared from Black6 13.5 d.p.c. mouse
embryos by trypsin digestion according to national regulations.
Transfection was performed using the calcium phosphate method.
25 ng expression vector and 500 ng of reporter were usually used
for each 35 mm well. Luciferase experiments were normalized to
the activity of Renilla Luciferase, after co-transfection of the tk-RL
plasmid (Promega) as described [52]. Measurements were done
with a Lumat LB9501 Luminometer (Berthold).
Transgenic Analysis
Animal care was performed according to national regulations
and experiments approved by the regional ethics committee of
Languedoc-Roussillon, France. Transgene DNA was separated
Figure 6. Validation of the expression profile and start site
region of c-fos intronic mRNA by RT-QPCR. A. Schematic
representation of the primers used in this RT-PCR study. Boxes
represent exons, larger boxes are translated regions, arrows depict
primers. The 39 PCR primer was always RT1. 59 primers in grey lie
upstream the putative TSS, whereas primers in black are downstream. B.
RT-PCR mapping of the c-fos intronic mRNA start site region. RNA
extracted from E12.5 mouse embryo mammary buds was reverse
transcribed with primer RT1, then cDNAs were amplified with primers
used for detection of the intronic mRNA (primer 2 lane d, primer 3 lane
e) and canonical pre-mRNA (primer 1, lane f). Minus RT control ensures
that no genomic DNA contaminant was amplified with any primer (-RT:
lanes a, b, c), while PCR on genomic DNA (genDNA: lanes g, h, i) shows
that primer 1 is PCR-competent (lane i). The DNA ladder (last lane) shows
fragments of 600, 500, 400, 300, and 200 bp. n=4. C. Quantitative PCR-
mediated mapping of the intronic mRNA start site on cDNA from adult
mouse cortex. The five different 59 primers described earlier were used
along with RT1 for amplification. Signal was normalized according to
standard curves elaborated for each primer pair, allowing a measure of
thetargetedRNAindependently ofprimer efficiency.Thescaleshowsthe
amount of RNA in fg per 10 ml of reaction. Error bars represent standard
deviation, n=4. D. RT-QPCR analysis of fos intronic mRNA expression in
adult tissues. Quantitative PCR was ran with primers 2 and RT1 on cDNA
prepared from dissected candidate adult mouse tissues (from left to
right: spinal chord, mammary gland, cerebellum, cortex, skin). Normal-
ization was done over the expression of beta-2 microgobulin. Error bars
represent standard deviation, n=4. Statistical analysis of variance
(ANOVA) was performed relative to primer 0.8 (C) or to spinal chord
level (D). *: p,0.05; **: p,0.01.
doi:10.1371/journal.pone.0011235.g006
fos Intronic Promoter
PLoS ONE | www.plosone.org 9 June 2010 | Volume 5 | Issue 6 | e11235from plasmid sequences by restriction digestion and gel electropho-
resis, purified on a sucrose gradient and injected (2 ng/ml) into the
pronuclei of fertilized embryos of (C57 Bl/6 CBA) F1 mice (from
Iffa-Credo, France). After incubation overnight, two-cell embryos
were transferred to the oviducts of pseudopregnant foster mothers.
Animals were genotyped by PCR using tail DNA and 2 primers
hybridizing respectively to c-fos first intron and LacZ cDNA
(59-gcgagttcattctggagact-39 and 59-gtaaaacgacgggatcgatc-39). PCR
genotyping was confirmed by southern blot analysis using a
32P-
labeled LacZ probe (random priming method, see [22]). Male
founders were mated to wild-type (C57 Bl/6 CBA) F1 females that
were then sacrificed by cervical disruption at different times post-
conception. Embryos were dissected out from uterus and yolk sac,
fixed 20 min in 4% Paraformaldehyde, rinsed in PBS (containing
NP-40 0.01% and deoxycholate 0.01% for embryos older than E12
and adult tissues), and incubated overnight at 30uC, pH 7.4 in PBS
containing 0.4 mg/ml X-Gal, potassium ferricyanide and ferrocy-
anide (4 mM each), and 4 mM MgCL2 (as described in [53]).
Embryos were either photographed with a stereomicroscope and
digital color camera, or sectionned in a cryotome, and the sections
counterstained with eosin, before photographing.
RT-PCR analysis
Total RNA was prepared from dissected mouse embryos or
adult tissues with TRIZOL reagent (Invitrogen) according to the
manufacturer’s directions, except that frozen tissues were homog-
enized with a FastPrepH-24 instrument (MP Biomedicals) and
zirconium beads before phase separation. RT was performed on
1 mg total RNA with 200 U superscript II enzyme (Invitrogen) and
ac - fos exon2 primer (RT1, 59-actagagacggacagatctg-39) or random
hexamers before DNase I (Roche) treatment and column
purification (nucleospin, Macherey-Nagel). For PCR, we used 1
tenth of the RT reaction, and the oligonucleotides used were RT1
and one of the following: primer 0.8 (59-gctaactagagtttgggagg-39),
primer 0.9 (59-gggtgtgtaaggcagtttca-39), primer 1 (59-gcgagtt-
cattctggagact-39, red in fig. 1B), primer 2 (59-ataacgggaacgcag-
cagta-39, in green in fig.1B) or primer 3 (59-tgcggaattcaagggaggat-
39). Quantitative PCR was ran on a Light Cycler 480 apparatus
(Roche) with Taq platinum (Invitrogen) and a SYBR Green mix
containing 3 mM MgCl2 and dNTPs 30 mM each. qPCR
conditions were 45 cycles as follows: 95uC for 4 s, 62uC for 10 s,
and 72uC for 30 s. Normalization was done according to beta-2
microglobulin housekeeping gene (selected for its constant
expression in the tissues tested), or according to a standard
dilution curve on a c-fos mouse gene-containing plasmid when
comparing targets amplified with different primers.
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